Medigene & BioNTech Extend T Cell Receptor Immunotherapy Collaboration
Breaking News Will enable ongoing and future work required to potentially generate novel TCRs directed against multiple newly nominated antigen targets. 05.21.24 Medigene AG, an immuno-oncology platform company focused on the discovery and development of …